Skip to content

Effects of Ciprofol Total Intravenous Anesthesia on Early Postoperative Recovery and Cognitive Function in Elderly Patients Undergoing Thoracoscopic Lobectomy

Effects of Ciprofol Total Intravenous Anesthesia on Early Postoperative Recovery and Cognitive Function in Elderly Patients Undergoing Thoracoscopic Lobectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600116483
Enrollment
Unknown
Registered
2026-01-11
Start date
2026-01-11
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Cognitive Dysfunction

Interventions

Propofol group:Propofol Group Anesthesia Protocol: Induction was achieved with intravenous propofol (1.5 mg/kg), sufentanil (0.2–0.4 µg/kg), and rocuronium (0.6 mg/kg). Anesthesia was maintained with
Ciprofol:Ciprofol Group Anesthesia Protocol: Induction was achieved with intravenous sufentanil (0.2–0.4 µg/kg), ciprofol (0.4 mg/kg), and rocuronium (0.6 mg/kg). Anesthesia was maintained with contin

Sponsors

Liaoning Cancer Hospital & Institute
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Patients scheduled to undergo video-assisted thoracoscopic surgery (VATS) lobectomy; (2) Patients willing to receive total intravenous anesthesia; (3) Patients aged between 65 and 80 years, with a body mass index (BMI) between 18 kg/m² and 30 kg/m²; (4) Patients classified as American Society of Anesthesiologists (ASA) physical status I or II; (5) Patients with no history of surgery within the past 3 months.

Exclusion criteria

Exclusion criteria: (1) Patients with a known allergy to any anesthetic drug used in this study; (2) Patients with a history of alcohol, sedative-analgesic, psychotropic substance abuse, or drug addiction; (3) Patients unable to cooperate with or complete the Mini-Mental State Examination (MMSE), or whose score falls below the specified thresholds (illiterate <= 17, primary school education <= 20, secondary school education <= 22, college education or above <= 23); (4) Patients with severe concomitant diseases, including significant cardiac, pulmonary, hepatic, renal, or endocrine disorders; (5) Patients currently taking sedative-opioids, sleep aids (e.g., benzodiazepines), or antidepressant medications (e.g., tricyclic, tetracyclic antidepressants, or selective serotonin reuptake inhibitors); (6) Patients who decline to participate in the study.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative cognitive dysfunction (POCD);Quality of postoperative recovery;Hemodynamics;

Countries

China

Contacts

Public ContactLi Songze,Hou baoxu

Liaoning Cancer Hospital & Institute

lisongze999@163.com+86 180 4139 4511

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026